The number of people with susceptibility test result for rifampicin in Australia
Australia: The number of people with susceptibility test result for rifampicin was 597 in 2021. ▼ Falling
Latest (2021)
597
Change on year
down 18.8%
World rank
76th
of 155 countries
All-time high
735
in 2020
All-time low
597
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Australia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Australia is 597, measured in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 18.8% on the previous year and down 13.2% over five years.
Australia ranks 76th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Australia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 688 | — |
| 2018 | 712 | +3.5% |
| 2019 | 708 | -0.6% |
| 2020 | 735 | +3.8% |
| 2021 | 597 | -18.8% |
Australia compared with similar countries
- Australia's 597 is above the median for high income countries, which is 142, 4.2× the median. (61 countries reporting)
- Australia's 597 is above the median for East Asia & Pacific, which is 185, 3.2× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 702.67 | 688 | 712 | 3 |
| 2020s | 666 | 597 | 735 | 2 |
Countries ranked near Australia
More health data for Australia
- Un projection of annual infant deaths, annual growth rate -1.83 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9072 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 906.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 215 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate 1.45 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0279 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.35 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Australia?
- The number of people with susceptibility test result for rifampicin in Australia was 597 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Australia?
- The highest recorded value was 735 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Australia?
- The lowest recorded value was 597 in 2021.
- How does Australia rank for the number of people with susceptibility test result for rifampicin?
- Australia ranks 76th out of 155 countries with data for 2021.
- Where does this Australia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).